Axsome Therapeutics Inc. (AXSM)
NASDAQ: AXSM
· Real-Time Price · USD
120.30
0.36 (0.30%)
At close: Oct 03, 2025, 3:59 PM
122.70
2.00%
After-hours: Oct 03, 2025, 06:58 PM EDT
0.30% (1D)
| Bid | 119 |
| Market Cap | 6B |
| Revenue (ttm) | 495.03M |
| Net Income (ttm) | -246.9M |
| EPS (ttm) | -5.06 |
| PE Ratio (ttm) | -23.77 |
| Forward PE | 109.04 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 125 |
| Volume | 306,911 |
| Avg. Volume (20D) | 591,515 |
| Open | 120.09 |
| Previous Close | 119.94 |
| Day's Range | 119.74 - 122.14 |
| 52-Week Range | 75.56 - 139.13 |
| Beta | 0.51 |
| Ex-Dividend Date | n/a |
About AXSM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AXSM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AXSM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAxsome Therapeutics Inc. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+3.42%
AXSM stock has given up its prior gain. Axsome The...
Unlock content with
Pro Subscription
2 months ago
+3.42%
Axsome Therapeutics shares are trading higher after the company reported better-than-expected Q2 financial results.
2 months ago · seekingalpha.com
Axsome Therapeutics, Inc. (AXSM) Q2 2025 Earnings Call TranscriptAxsome Therapeutics, Inc. (NASDAQ:AXSM ) Q2 2025 Earnings Conference Call August 4, 2025 8:00 AM ET Company Participants Ari Maizel - Chief Commercial Officer Darren Opland - Corporate Participant Her...
